2819-68-3

Usage

InChI:InChI=1/C15H18O3/c16-13-8-4-5-10-15(13,11-9-14(17)18)12-6-2-1-3-7-12/h1-3,6-7H,4-5,8-11H2,(H,17,18)

Upstream product

• 32231-10-0 2-(2'-Cyano-ethyl)-2-phenyl-cyclohexan-1-on 
• 1444-65-1 (RS)-2-phenylcyclohexanone 
• 13128-18-2 4a-Phenyl-Δ⁸-octahydro-chinol-2-on 

Downstream Products

• 204118-19-4 3-(2-oxo-1-phenyl-cyclohexyl)-propionic acid methyl ester 
• 1356464-87-3 1-(4-(5-(2-(1-phenylcyclohexyl)ethyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid 
• 1356464-90-8 methyl 1-(4-(5-(2-(2-oxo-1-phenylcyclohexyl)ethyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate 
• 1356465-60-5 N-(2-hydroxy-2-(4-(5-(2-(1-phenylcyclohexyl)ethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)-β-alanine 
• 1356606-33-1 (Z)-methyl 1-(4-(N'-(3-(2-oxo-1-phenylcyclohexyl)propanoyloxy)carbamimidoyl)benzyl)azetidine-3-carboxylate 

Relevant academic research and scientific papers

SUBSTITUTED 3-PHENYL-1,2,4-OXADIAZOLE COMPOUNDS

Disclosed are compounds of Formula (I): (I) or stereoisomers, salts, or prodrugs thereof, wherein: (i) R1 and R2 are independently C1-C4 alkyl, or (ii) R1 and R2 together with the carbon atom to which they are a

SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS S1P1 AGONISTS

Disclosed are compounds of Formula (I): [PLEASE INSERT CHEMICAL STRUCTURE HERE] or stereoisomers, N-oxides, salts, or prodrugs thereof; wherein: Ring A is phenyl or 5- to 6-membered heteroaryl; (i) R1 and R2 are independently C1-C4 alkyl; or (ii) R1 and R